SunLink Health Systems Azioni (AMEX: SSY)

Ultime notizie per SunLink Health Systems (AMEX:SSY) Azioni

SunLink Health Systems

SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operate licensed-bed, acute care hospitals, which includes bed geriatric psychology unit, and nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.

SunLink Health Systems, Inc. Common Stock

SunLink Health Systems Inc

SENSYNE HEALTH LTD by Sensyne Health Ltd.

Sassy Gold Corp Ordinary Shares

Sassy Gold Corp

Stratasys Ltd

With U.S. stock futures trading slightly lower this morning on Friday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects JPMorgan Chase &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) to report quarterly earnings at $4.01 per share on revenue of $41.65 billion before the opening bell, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. JPMorgan shares fell 0.1% to $212.56 in after-hours trading.</li>
<li>SunLink Health Systems, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSY#NYSE">SSY</a>) announced the sale of its Trace regional hospital real estate for $2 million. SunLink Health shares gained 6% to $0.86 in after-hours trading.</li>
<li>Analysts are expecting Wells Fargo &amp; Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>) to post quarterly earnings at $1.28 per share on revenue of $20.41 billion. The company will release earnings before the markets open. Wells Fargo shares gained 0.1% to $57.80 in after-hours trading.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<ul>
<li>Before the markets open, Fastenal Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FAST#NASDAQ">FAST</a>) is projected to report quarterly earnings at 51 cents per share on revenue of $1.91 billion. Fastenal shares fell 0.6% to $69.60 in after-hours trading.</li>
<li>Analysts expect The Bank of New York Mellon Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BK#NYSE">BK</a>) to post quarterly earnings at $1.42 per share on revenue of $4.54 billion before the opening bell. Bank of New York Mellon shares gained 0.6% to $74.89 in after-hours trading.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/news/24/10/41272079/top-2-health-care-stocks-that-are-ticking-portfolio-bombs">Top 2 Health Care Stocks That Are Ticking Portfolio Bombs</a></li>
</ul>
Photo courtesy: Shutterstock

Earnings

Long Ideas

News

Pre-Market Outlook

Markets

Trading Ideas

FAST

JPMorgan, Wells Fargo And 3 Stocks To Watch Heading Into Friday

<h3>Gainers</h3>
<ul>
<li>NewGenIvf Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIVF#NASDAQ">NIVF</a>) shares rose 58.1% to $0.95 during Thursday's after-market session. The company's market cap stands at $9.6 million. </li>
<li>SunLink Health Systems (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SSY#AMEX">SSY</a>) shares increased by 17.13% to $0.95. The company's market cap stands at $6.6 million. </li>
<li>Akanda (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKAN#NASDAQ">AKAN</a>) shares increased by 5.55% to $1.14. The company's market cap stands at $3.2 million. </li>
<li>Butterfly Network (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BFLY#NYSE">BFLY</a>) shares moved upwards by 5.17% to $1.83. The market value of their outstanding shares is at $389.0 million. </li>
<li>Nurix Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRIX#NASDAQ">NRIX</a>) shares moved upwards by 5.16% to $22.99. The market value of their outstanding shares is at $1.4 billion. </li>
<li>Kindly MD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KDLY#NASDAQ">KDLY</a>) shares moved upwards by 5.07% to $1.34. The market value of their outstanding shares is at $7.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Klotho Neurosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLTO#NASDAQ">KLTO</a>) stock fell 6.5% to $0.45 during Thursday's after-market session. The market value of their outstanding shares is at $9.5 million. </li>
<li>Phio Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHIO#NASDAQ">PHIO</a>) shares declined by 5.1% to $2.42. The market value of their outstanding shares is at $2.0 million. </li>
<li>Humana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>) stock declined by 4.76% to $239.49. The market value of their outstanding shares is at $28.8 billion. </li>
<li>Processa Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCSA#NASDAQ">PCSA</a>) stock declined by 4.69% to $1.22. The market value of their outstanding shares is at $3.9 million. </li>
<li>Tango Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNGX#NASDAQ">TNGX</a>) shares fell 4.59% to $6.25. The market value of their outstanding shares is at $669.6 million. </li>
<li>Regencell Bioscience (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) stock declined by 4.5% to $6.59. The company's market cap stands at $85.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

AKAN

BFLY

KDLY

KLTO

NIVF

NRIX

PCSA

PHIO

TNGX

12 Health Care Stocks Moving In Thursday's After-Market Session

WIIM

SunLink Health Systems shares are trading higher after the company announced the sale of its Trace regional hospital real estate for $2 million.

Asset Sales

SunLink Health Systems Sells Trace Regional Hospital Real Estate For $2M, Retains $1.93M Net Proceeds For Working Capital And Strategic Transaction Opportunities

Reported Earlier, SunLink Health Systems Q4 EPS $0.61 Up From $(0.20) YoY, Sales $7.91M Down From $8.01M YoY

<h3>Gainers</h3>
<ul>
<li>Concord Medical Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCM#NYSE">CCM</a>) shares moved upwards by 131.0% to $4.85 during Tuesday's after-market session. The company's market cap stands at $210.6 million. </li>
<li>Calidi Biotherapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CLDI#AMEX">CLDI</a>) stock increased by 4.26% to $0.21. The market value of their outstanding shares is at $10.8 million. </li>
<li>Anitra (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AZTR#AMEX">AZTR</a>) shares moved upwards by 2.69% to $0.18. The market value of their outstanding shares is at $5.0 million. </li>
<li>MAIA Biotechnology (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MAIA#AMEX">MAIA</a>) stock rose 0.79% to $3.79. The company's market cap stands at $82.7 million. </li>
<li>Emergent BioSolutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBS#NYSE">EBS</a>) shares moved upwards by 0.53% to $5.59. The market value of their outstanding shares is at $292.9 million. </li>
<li>Asensus Surgical (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ASXC#AMEX">ASXC</a>) shares increased by 0.38% to $0.24. The market value of their outstanding shares is at $64.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>BiomX (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PHGE#AMEX">PHGE</a>) stock fell 4.7% to $0.4 during Tuesday's after-market session. The market value of their outstanding shares is at $28.0 million. </li>
<li>SunLink Health Systems (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SSY#AMEX">SSY</a>) shares declined by 3.8% to $0.68. The company's market cap stands at $4.7 million. </li>
<li>Scorpius Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SCPX#AMEX">SCPX</a>) shares fell 3.55% to $0.12. The market value of their outstanding shares is at $11.8 million. </li>
<li>MultiPlan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MPLN#NYSE">MPLN</a>) shares decreased by 1.19% to $0.47. The market value of their outstanding shares is at $300.1 million. </li>
<li>IGC Pharma (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/IGC#AMEX">IGC</a>) shares fell 0.97% to $0.47. The company's market cap stands at $35.4 million. </li>
<li>Nanoviricides (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NNVC#AMEX">NNVC</a>) shares decreased by 0.78% to $2.4. The company's market cap stands at $28.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ASXC

AZTR

CLDI

MAIA

MPLN

NNVC

PHGE

SCPX

12 Health Care Stocks Moving In Tuesday's After-Market Session

SunLink Health Systems Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSY#NASDAQ">SSY</a>) shares are trading higher by 13.4% to $0.68 during Tuesday's session after the company late Monday announced that its subsidiary, Southern Health Corporation of Houston, has sold the Trace Extended Care &amp; Rehab senior care facility and related real estate in Houston, Mississippi <a href="https://www.benzinga.com/pressreleases/24/06/b39148432/sunlink-health-systems-inc-announces-sale-of-trace-extended-care-rehab">for around $7.1 million</a>. 
The net proceeds of about $6.5 million will be used for working capital and general corporate purposes. The sale is expected to result in a pre-tax gain of approximately $5.7 million in the fourth fiscal quarter ending June 30.&nbsp;
This sale aligns with SunLink&#8217;s strategy to position itself for a potential extraordinary transaction, such as a merger or consolidation, improve its operations, and consider selling non-performing assets. The company aims to find a strategic transaction that offers shareholders a chance for future value appreciation with acceptable risk.
See Also: <a href="https://www.benzinga.com/news/24/06/39148996/dave-portnoy-blasts-e-trade-amid-roaring-kitty-ban-considerations">Dave Portnoy Blasts E&#x2A;Trade Amid Roaring Kitty Ban Considerations</a>
<h1 class="wp-block-heading">How To Buy SSY Stock</h1>
By now you're likely curious about how to participate in the market for SunLink Health Systems &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of<a href="https://www.benzinga.com/money/best-stock-trading-platforms"> possible trading platforms here.</a> Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, or Amazon.com, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.
In the the case of SunLink Health Systems, which is trading at $0.6 as of publishing time, $100 would buy you 166.67 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a<a href="https://www.benzinga.com/money/how-to-short-a-stock"> stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, SSY has a 52-week high of $1.05 and a 52-week low of $0.53.

Why SunLink Health Systems (SSY) Stock Is Moving

SunLink Health Systems shares are trading higher after the company's subsidiary, Southern Health Corporation of Houston, completed the sale of Trace Extended Care & Rehab.

<h3>Gainers</h3>
<ul>
<li>Annexon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANNX#NASDAQ">ANNX</a>) shares increased by 57.2% to $7.2 during Tuesday's pre-market session. The market value of their outstanding shares is at $665.3 million. </li>
<li>Fresh2 Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRES#NASDAQ">FRES</a>) shares moved upwards by 36.08% to $0.48. The company's market cap stands at $11.8 million. </li>
<li>SunLink Health Systems (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SSY#AMEX">SSY</a>) stock moved upwards by 32.45% to $0.8. The market value of their outstanding shares is at $5.6 million. </li>
<li>Adlai Nortye (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANL#NASDAQ">ANL</a>) stock moved upwards by 15.96% to $7.12. The market value of their outstanding shares is at $262.7 million. </li>
<li>TRACON Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCON#NASDAQ">TCON</a>) shares rose 15.74% to $1.47. The market value of their outstanding shares is at $3.9 million. </li>
<li>Kindly MD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KDLY#NASDAQ">KDLY</a>) stock increased by 15.41% to $3.07. The company's market cap stands at $18.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Bio-Path Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BPTH#NASDAQ">BPTH</a>) shares declined by 24.1% to $2.45 during Tuesday's pre-market session. The market value of their outstanding shares is at $4.0 million. </li>
<li>Exicure (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XCUR#NASDAQ">XCUR</a>) shares declined by 9.3% to $0.49. The market value of their outstanding shares is at $4.2 million. </li>
<li>Sharps Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STSS#NASDAQ">STSS</a>) shares decreased by 8.88% to $0.35. The market value of their outstanding shares is at $5.4 million. </li>
<li>MyMD Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYMD#NASDAQ">MYMD</a>) shares decreased by 8.17% to $1.8. The company's market cap stands at $4.1 million. </li>
<li>NewGenIvf Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIVF#NASDAQ">NIVF</a>) stock decreased by 7.98% to $1.27. The market value of their outstanding shares is at $12.8 million. </li>
<li>Mainz Biomed (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYNZ#NASDAQ">MYNZ</a>) shares decreased by 7.84% to $0.8. The company's market cap stands at $17.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ANNX

BPTH

FRES

MyMD Pharmaceuticals, Inc. - Common Stock

MYMD

MYNZ

STSS

TCON

XCUR

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Shares of Healthequity Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HQY#NASDAQ">HQY</a>) rose sharply in today's pre-market trading as the company reported better-than-expected <a href="https://www.benzinga.com/news/earnings/24/06/39147010/healthequity-stock-climbs-after-better-than-expected-q1-results-strong-forward-guidance">first-quarter financial results</a>.
The company reported quarterly earnings of 80 cents per share which beat the analyst consensus estimate of 66 cents, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. HealthEquity issued strong FY25 earnings guidance and also issued FY25 revenue guidance with its midpoint above expectations.
Healthequity shares jumped 5.9% to $85.98 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>MicroAlgo Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLGO#NASDAQ">MLGO</a>) rose 209.5% to $4.83 in today's pre-market trading. WiMi Hologram Cloud and MicroAlgo announced plans to jointly establish a micro-consciousness quantum research center.</li>
<li>Core Scientific Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORZ#NASDAQ">CORZ</a>) shares gained 51.8% to $7.39 in pre-market trading. Core Scientific announced the signing of a series of 12-year contracts with CoreWeave, the AI Hyperscaler.</li>
<li>Annexon, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANNX#NASDAQ">ANNX</a>) gained 31.2% to $6.01 in pre-market trading. Annexon will host a conference call and webcast on Tuesday at 8:30 a.m. ET to discuss GBS phase 3 data.</li>
<li>Plutonian Acquisition Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTN#NASDAQ">PLTN</a>) gained 29.9% to $8.60 in pre-market trading.</li>
<li>SunLink Health Systems Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSY#NYSE">SSY</a>) shares rose 24.1% to $0.75 in pre-market trading. SunLink Health Systems said its subsidiary, Southern Health Corporation of Houston, Inc., has completed the sale of its Trace Extended Care &amp; Rehab senior care facility and related real estate in Houston, Mississippi.</li>
<li>FibroGen Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGEN#NASDAQ">FGEN</a>) gained 18.6% to $1.46 in pre-market trading after the company announced announced that the FDA cleared its Investigational New Drug of FG-3165. Also, the company announced a clinical trial supply agreement with Regeneron Pharmaceuticals to evaluate FG-3165 and FG-3175 in combination with LIBTAYO.</li>
<li>WiMi Hologram Cloud Inc &#8211; ADR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WIMI#NASDAQ">WIMI</a>) rose 15.1% to $0.99 in pre-market trading. WiMi Hologram Cloud and MicroAlgo announced plans to jointly establish a micro-consciousness quantum research center.</li>
<li>Captivision Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPT#NASDAQ">CAPT</a>) shares climbed 14.2% to $3.87 in pre-market trading after dipping 28% on Monday.</li>
<li>Lexaria Bioscience Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEXX#NASDAQ">LEXX</a>) shares gained 13.8% to $4.43 in pre-market trading.  </li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Lufax Holding Ltd &#8211; ADR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LU#NYSE">LU</a>) shares declined 51.1% to $2.14 in pre-market trading.</li>
<li>Avalon Globocare Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALBT#NASDAQ">ALBT</a>) shares declined 26.2% to $0.91 in pre-market trading after surging 317% on Monday.</li>
<li>Hywin Holdings Ltd &#8211; ADR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYW#NASDAQ">HYW</a>) shares dipped 22.7% to $0.52 in pre-market trading after jumping 91% on Monday.</li>
<li>MingZhu Logistics Holdings Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YGMZ#NASDAQ">YGMZ</a>) shares fell 16.5% to $0.39 in pre-market trading. MingZhu Logistics Holdings shares jumped 32% on Monday after the company announced an agreement to acquire Oxylus Global.</li>
<li>NewGenIvf Group Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIVF#NASDAQ">NIVF</a>) shares fell 13.8% to $1.19 in pre-market trading. On Monday, NewGenIvf signed a non-binding $617.34 million deal for potential reverse merger with pharma company COVIRIX.</li>
<li>Microbot Medical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBOT#NASDAQ">MBOT</a>) shares fell 13% to $1.20 in pre-market trading after jumping 38% on Monday.</li>
<li>Sequans Communications SA ADR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SQNS#NYSE">SQNS</a>) shares fell 11.9% to $0.60 in pre-market trading after declining around 10% on Monday.</li>
<li>Bark Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BARK#NYSE">BARK</a>) shares declined 10.7% to $1.25 in pre-market trading after the company reported downbeat financial results for its fourth quarter and issued FY25 revenue guidance below estimates.</li>
<li>ICICI Bank Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBN#NYSE">IBN</a>) shares fell 8.7% to $25.85 in pre-market trading after gaining around 6% on Monday.</li>
<li>HDFC Bank Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HDB#NYSE">HDB</a>) fell 7.8% to $56.47 in pre-market trading after gaining around 6% on Monday.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/earnings/24/06/39152576/investor-sentiment-improves-but-dow-falls-over-100-points">Investor Sentiment Improves, But Dow Falls Over 100 Points</a>

ALBT

BARK

CAPT

Core Scientific, Inc. - Class A Common Stock

CORZ

FGEN

LEXX

MBOT

MLGO

PLTN

SQNS

WIMI

YGMZ

Why HealthEquity Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

SunLink Health Systems Q3 2024 EPS $(0.12) Down From $(0.06) YoY; Revenue $7.462M Down From $8.181M YoY

SunLink Health Systems (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SSY#AMEX">SSY</a>) reported quarterly losses of $(0.06) per share. This is a 120.69 percent decrease over earnings of $0.29 per share from the same period last year. The company reported $8.51 million in sales this quarter. This is a 40.87 percent decrease over sales of $14.39 million the same period last year.

SunLink Health Systems Q2 EPS $(0.06) Down From $0.29 YoY, Sales $8.51M Down From $14.39M YoY

Sunlink Health Systems' Subsidiary Reaches Revised Agreements For Sale Of Trace Regional Medical Center And Clinics; Sold Property To Progressive For $500,000; Six-Month Net Lease For $20,000/Month; Terminates Nov. 10, 2023 Transaction

SunLink Health Systems (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SSY#AMEX">SSY</a>) reported quarterly losses of $(0.06) per share. This is a 72.73 percent increase over losses of $(0.22) per share from the same period last year. The company reported $8.55 million in sales this quarter. This is a 22.49 percent decrease over sales of $11.04 million the same period last year.

SunLink Health Systems Q1 EPS $(0.06) Up From $(0.22) YoY, Sales $8.55M Down From $11.04M YoY

SunLink Health Systems, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMERICAN#NYSE">AMERICAN</a>) today announced that its subsidiary, Crown Healthcare Investments, LLC, has signed an agreement with Progressive Health Group, LLC ("Buyer") for the sale of the subsidiary that owns and operates Trace Regional Medical Center, which includes a hospital, skilled nursing facility and three (3) patient clinics in Chickasaw County, MS, for approximately $8,000,000. The sale is subject to, among other things, the Buyer's satisfactory completion of its due diligence investigation and a number of customary closing conditions. The company expects to recognize a pre-tax gain of approximately $1,700,000 on the transaction, which is scheduled to close on December 15, 2023. The transaction will therefore be reported in SunLink Health Systems, Inc.'s second fiscal quarter. The proceeds of the sale of approximately $7,500,000, after payment of closing costs, will be used for general corporate purposes.
As a result of the Company's agreement on November 10, 2023 to sell Trace Regional Medical Center, SunLink Health Systems, Inc. will delay its filing with the U. S. Securities and Exchange Commission ("SEC") of its quarterly report on Form 10-Q for the period ended September 30, 2023, which is due by November 14, 2023. Because of the sale date, the Company needs additional time to prepare its financial statements for the quarterly period ended September 30, 2023. A Form 12b-25 will be filed with the SEC which allows for an automatic extension of five calendar days to file the Form 10-Q and have it be considered a timely filing. SunLink Health Systems, Inc. intends to file its Form 10-Q report of the quarterly period ended September 30, 2023 by the end of the five calendar day extension period.

Contracts

AMERICAN

SunLink Health Systems Reaches Agreement For Sale Of Trace Regional Medical Center For Approximately $8M

SunLink Health Systems shares are trading lower. The company reported Q4 financial results.

SunLink Health Systems (AMEX:SSY) reported quarterly losses of $(0.20) per share. This is a 39.39 percent increase over losses of $(0.33) per share from the same period last year. The company reported $10.99 million inSunLink Health Systems (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SSY#AMEX">SSY</a>) reported quarterly losses of $(0.20) per share. This is a 39.39 percent increase over losses of $(0.33) per share from the same period last year. The company reported $10.99 million in sales this quarter. This is a 11.19 percent increase over sales of $9.88 million the same period last year.

SunLink Health Systems Q4 Reported Thursday EPS $(0.20) Up From $(0.33) YoY, Sales $10.99M Up From $9.88M YoY

SunLink Health Systems (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SSY#AMEX">SSY</a>) reported quarterly losses of $(0.11) per share. This is a 21.43 percent increase over losses of $(0.14) per share from the same period last year. The company reported $11.53 million in sales this quarter. This is a 9.56 percent increase over sales of $10.53 million the same period last year.

SunLink Health Systems Q3 EPS $(0.11) Up From $(0.14) YoY, Sales $11.53M Up From $10.53M YoY

Guidance

Sysco Corp Says Expect To End The Year Near The Bottom Of Adjusted EPS Fiscal 2023 Guidance Range Of $4-$4.15

Eugene Burleson Named Chairman of The Board
Forms Scientific Advisory Board Led by Academic Thought Leaders Dr. Bernard C. Camins at Mt. Sinai Health System, Dr. Christopher E. Mason at Cornell University and&nbsp;World-Renowned Winemaker Mark Beringer
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fapplieduvinc.com%2Fsterilumen%2F&amp;esheet=53378740&amp;newsitemid=20230411005175&amp;lan=en-US&amp;anchor=Applied+UV%2C+Inc.&amp;index=1&amp;md5=9fadd458916542faeb49eb82bde46e08">Applied UV, Inc.</a>&nbsp;(NasdaqCM:&nbsp;<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Firdirect.net%2FAUVI&amp;esheet=53378740&amp;newsitemid=20230411005175&amp;lan=en-US&amp;anchor=AUVI&amp;index=2&amp;md5=33f5003cec339c36192391140cce7e16">AUVI</a>) (&quot;Applied UV&quot; or the &quot;Company&quot;), a global leading provider of patented, scientifically and clinically proven surface and air pathogen elimination and disinfection technologies (fixed, mobile, and HVAC), LED lighting products and premium hotel furnishings, announces today the following leadership appointments following the completion of Applied UV&#39;s acquisition of Puro Lighting, LLC (&quot;PURO&quot;) and LED Supply Co. (&quot;LED Supply&quot;). Eugene Burleson who has served on Applied UV&#39;s Board of Directors since 2020 has been named Chairman of the Board. Max Munn, the Company&#39;s Founder, and a member of the Board of Directors and, has been serving as the interim CEO, has been appointed CEO and President of Applied UV. Brian Stern, chief executive officer and co-founder of PURO, and Andrew Lawrence, chief operating officer and co-founder of PURO and LED Supply have joined the Company&#39;s management team.
In addition, the Company has formed a Global Scientific Advisory Board and appointed Dr. Bernard C. Camins, Dr. Christopher E. Mason and Mark Beringer to serve as advisors.
Max Munn, Founder, CEO and Director stated, &quot;Gene Burleson has provided us sound counsel since he joined our Board. I championed his elevation to serve as our chairman. Having two of the founders join our ranks will help to ensure timely execution of the integration of Puro and LED Supply. The addition of these distinguished thought leaders to our Scientific Advisory Board will help drive the adoption of our entire suite of air and surface pathogen elimination portfolio by our customers and potential customers. We welcome all these esteemed individuals to the Applied UV Family.&quot;
Mark Beringer, a member of Applied UV&#39;s Scientific Advisory Board and Chief Wine Maker at Phantom Creek Estates in the Okanagan Valley, BC stated, &quot;We utilize our Airocide systems to protect our most valued assets, our oak fermentation tanks. These vessels represent a huge investment, and they must be meticulously maintained from drying out or becoming contaminated with any foreign yeast, bacteria, molds, or mildews. We keep our rooms at a high level of relative humidity, so we count on the Airocide units to keep the air clean and free of any organism or Volatile Organic Compounds (&quot;VOCs&quot;) that could potentially damage the wood vessels or the wines within them. With Airocide our rooms are hospital level clean.&quot;
Executive Management and Board of Director Appointments
Eugene Burleson&nbsp;&ndash; Has been a member of our Board of Directors since our IPO. He is a private investor, currently a director and Chairman of the Compensation Committee of Sunlink Health Systems, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSY#NYSE">SSY</a>), an investor in healthcare facilities and related businesses located in the Southeast, and a director and the Chairman of the Compensation Committee of HealthNow New York, a private health insurance company. He was Chairman of PET DRx Corporation from June 2005 to July 1, 2010, and its Chief Executive Officer from October 2008 until its acquisition by VCA Antech in July 2010. Mr. Burleson was a director of HealthMont Inc. from September 2000 until its acquisition by SunLink in October 2003. Mr. Burleson served as Chairman of the Board of Directors of Mariner Post-Acute Network, Inc. from January 2000 to June 2002. Mr. Burleson also served as Chairman of the Board of Directors of Alterra Healthcare Inc., a developer and operator of assisted living facilities and is on the Board of Deckers Outdoor Corporation Inc. Mr. Burleson served as Chairman of the Board and Chief Executive Officer of GranCare Inc. from October 1988 to November 2000. Additionally, Mr. Burleson served as President and Chief Executive Officer of GranCare Inc. from December 1990 to February 1997. Upon completion of the merger of GranCare&#39;s pharmacy operations with Vitalink Pharmacy Services Inc. in February 1997, he became Chief Executive Officer and a Director of Vitalink Pharmacy Services Inc. Mr. Burleson resigned as Chief Executive Officer and Director of Vitalink Pharmacy Services in August 1997. From June 1986 to March 1989, Mr. Burleson served as President, Chief Operating Officer, and a Director of American Medical International Inc. (&quot;AMI&quot;), an owner and operator of acute care hospitals. Based in London from May 1981 to June 1986, Mr. Burleson served as Managing Director of AMI&#39;s international operations. Mr. Burleson received his early management training at Eastman Kodak from 1963 to 1974. He graduated from East Tennessee State University with a Bachelor of Science Degree in accounting and earned an MBA degree in 1972.
Brian Stern and Lawrence Webb join Applied UV&#39;s leadership team as the Company continues the global market expansion of its patented, disruptive, and highly effective suite of surface and air pathogen elimination and disinfection solutions, which now includes the PURO and LED Supply suite of products. Mr. Stern has been appointed to the role of President of PURO Lighting and will serve as a Director on the Board of Applied UV. Mr. Webb has been appointed to the role of president of LED Supply.
Brian Stern&nbsp;most recently served as chief executive officer and co-founder of PURO Lighting Inc. and LED Supply Co. which merged with Applied UV in January 2023. Brian is a visionary entrepreneur and University of Denver alum with a BS in Business Administration who has made a significant impact in the business world. With the co-founding of LED Supply Co. in 2007 and Puro Lighting in 2019, Brian established himself as a leader in both the LED lighting and UV disinfection markets. Under his direction, LED Supply. was recognized multiple times by&nbsp;Inc. Magazine&nbsp;as one of the fastest growing companies in the country. With Puro, Brian secured some of the largest contracts for UV disinfection and implemented cutting-edge UVC technology on a nationwide scale. As CEO of both companies, Brian drove their meteoric rise to become one of the fastest growing companies in the United States.
Andrew Lawrence&nbsp;most recently served as chief operating officer and co-founder of PURO Lighting Inc., and LED Supply. He began his professional career in the radio ad sales industry working for a top Denver station where he developed his skills as a salesperson to quickly became the top revenue generator for the firm. In 2009, Andrew co-founded LED Supply Co. with his partner, Brian Stern. As a small business owner/operator, Andrew gained extensive experience in people management, human resources, business operations, key account development and business strategy. In 2018, together with Mr. Stern and Jim Colantoni, Andrew co-founded PURO Lighting, providing ground-breaking UV light technology to help bring clinical-level disinfection to wherever people gather. As Andrew moves into his new role as president of LED Supply, he has the benefit of continuing to manage and work with the same strong team of people he has developed over the past 14 years.

Management

AUVI

Applied UV Strengthens Leadership With Executive And Board Appointments; Eugene Burleson Named Chairman Of The Board

SunLink Health Systems reaches agreement for sale of Trace Regional Medical Center

SunLink Health Systems GAAP EPS of -$0.19, revenue of $8.55M

SunLink Health Systems GAAP EPS of -$0.06, revenue of $8.51M

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
SunLink Health Systems (NYSEMKT:<a href="https://investorplace.com/stock-quotes/ssy-stock-quote/">SSY</a>) just reported results for the third quarter of 2024.<ul><li>SunLink Health Systems reported earnings per share of -20 cents.</li><li>The company reported revenue of $7.46 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/ssy-stock-earnings-sunlink-health-systems-for-q3-of-2024/">SSY Stock Earnings: SunLink Health Systems Reported Results for Q3 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

SSY Stock Earnings: SunLink Health Systems Reported Results for Q3 2024

SunLink Health Systems GAAP EPS of -$0.20, revenue of $7.5M

SunLink Health Systems announces sale of Trace Extended Care & Rehab

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to start Tuesday with a breakdown of the biggest pre-market stock movers traders will want to know about this morning!



Moving stocks this morning are new agreements and deals, clinical trial data, a bankruptcy filing and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>MicroAlgo (NASDAQ:<a href="https://investorplace.com/stock-quotes/mlgo-stock-quote/">MLGO</a>) stock is rocketing more than 205% after announcing a <a href="https://www.nasdaq.com/press-release/microalgo-inc-nasdaq-mlgo-announced-jointly-establish-micro-consciousness-quantum">joint micro-consciousness quantum research center</a> with WIMI (NASDAQ:<a href="https://investorplace.com/stock-quotes/wimi-stock-quote/">WIMI</a>).</li>



<li>Fresh2 Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/fres-stock-quote/">FRES</a>) shares are soaring over 74% alongside heavy pre-market trading.</li>



<li>Core Scientific (NASDAQ:<a href="https://investorplace.com/stock-quotes/corz-stock-quote/">CORZ</a>) stock is surging more than 48% on an <a href="https://www.businesswire.com/news/home/20240603752657/en/Core-Scientific-to-Provide-Approximately-200-MW-of-Infrastructure-to-Host-CoreWeave%E2%80%99s-High-Performance-Computing-Services-Capturing-Significant-AI-Compute-Opportunity">artificial intelligence (AI) infrastructure deal</a>.</li>



<li>Annexon (NASDAQ:<a href="https://investorplace.com/stock-quotes/annx-stock-quote/">ANNX</a>) shares are increasing over 33% on positive <a href="https://www.nasdaq.com/press-release/annexon-announces-positive-topline-results-pivotal-phase-3-trial-first-class-c1q">Phase 3 clinical trial results</a>.</li>



<li>Plutonian Acquisition (NASDAQ:<a href="https://investorplace.com/stock-quotes/pltn-stock-quote/">PLTN</a>) stock is rising close to 30% without any clear news this morning.</li>



<li>Datasea (NASDAQ:<a href="https://investorplace.com/stock-quotes/dtss-stock-quote/">DTSS</a>) shares are gaining more than 21% on Tuesday morning.</li>



<li>SunLink Health Systems (NYSEMKT:<a href="https://investorplace.com/stock-quotes/ssy-stock-quote/">SSY</a>) stock is climbing over 21% after <a href="https://www.nasdaq.com/press-release/sunlink-health-systems-inc-announces-sale-trace-extended-care-rehab-2024-06-03">selling some of its assets</a>.</li>



<li>Lexaria Bioscience (NASDAQ:<a href="https://investorplace.com/stock-quotes/lexx-stock-quote/">LEXX</a>) shares are heading 18% higher on a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318368667&amp;type=PDF&amp;symbol=LEXX&amp;cdn=3c5f428b59a4d15cb4a8011d5c00dc9b&amp;companyName=Lexaria+Bioscience+Corp.&amp;formType=S-1&amp;formDescription=Registration+statement+under+Securities+Act+of+1933&amp;dateFiled=2024-06-03">secondary stock offering</a>.</li>



<li>FibroGen (NASDAQ:<a href="https://investorplace.com/stock-quotes/fgen-stock-quote/">FGEN</a>) stock is jumping more than 16% on a <a href="https://finance.yahoo.com/news/fibrogen-announces-clinical-trial-supply-200500592.html">new clinical trial agreement</a>.</li>



<li>Adlai Nortye (NASDAQ:<a href="https://investorplace.com/stock-quotes/anl-stock-quote/">ANL</a>) shares are up nearly 16% on Tuesday.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Lufax (NYSE:<a href="https://investorplace.com/stock-quotes/lu-stock-quote/">LU</a>) stock is plummeting more than 51% without any apparent news from the company.</li>



<li>Hywin (NASDAQ:<a href="https://investorplace.com/stock-quotes/hyw-stock-quote/">HYW</a>) shares are diving over 24% after a massive rally on Monday.</li>



<li>Avalon Globocare (NASDAQ:<a href="https://investorplace.com/stock-quotes/albt-stock-quote/">ALBT</a>) stock is tumbling more than 20% after a major rally yesterday.</li>



<li>Binah Capital (NASDAQ:<a href="https://investorplace.com/stock-quotes/bcg-stock-quote/">BCG</a>) shares are taking an over 17% beating without any news to report today.</li>



<li>CalAmp (NASDAQ:<a href="https://investorplace.com/stock-quotes/camp-stock-quote/">CAMP</a>) stock is sliding more than 15% following <a href="https://finance.yahoo.com/news/calamp-reaches-comprehensive-agreement-significantly-132500316.html">a bankruptcy filing</a>.</li>



<li>Sequans Communications (NYSE:<a href="https://investorplace.com/stock-quotes/sqns-stock-quote/">SQNS</a>) shares are dropping over 14% on Tuesday morning.</li>



<li>Direxion Daily MSCI India Bull 2X Shares (NYSEARCA:<a href="https://investorplace.com/stock-quotes/indl-stock-quote/">INDL</a>) are falling more than 14% this morning.</li>



<li>MingZhu Logistics (NASDAQ:<a href="https://investorplace.com/stock-quotes/ygmz-stock-quote/">YGMZ</a>) stock is slipping over 14% after a rally yesterday.</li>



<li>Primech (NASDAQ:<a href="https://investorplace.com/stock-quotes/pmec-stock-quote/">PMEC</a>) shares are dipping 14% after jumping yesterday.</li>



<li>A2Z Smart Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/az-stock-quote/">AZ</a>) stock closes out our pre-market stock movers down over 12%.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-tuesday-june-4th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Sunlink Health Systems (SSY) just unveiled an announcement. Howard E. Turner stepped down from his position on the Board of Directors at SunLink He...

SunLink Health Systems Board Member Howard Turner Resigns

SunLink Health sells hospital building, related real estate of Trace Regional Hospital

CAMP

DTSS

INDL

PMEC

Press Releases

SunLink Health Systems Reaches Agreement for Sale of Trace Regional Medical Center

Micro Cap Bid Up Following Asset Sale Announcement

SunLink Health Systems, Inc. Announces Fiscal 2024 First Quarter Results

SunLink Health Systems, Inc. and Progressive Health Group, LLC, Agree to Extend the Closing Date of Their Previously-Announced Sale of Trace Regional Medical Center

Sunlink Health Systems' Subsidiary Reaches Revised Agreements for the Sale of Trace Regional Medical Center and Clinics

SunLink Health Systems, Inc. Announces Fiscal 2024 Second Quarter Results

SunLink Health Systems, Inc. Announces Fiscal 2024 Third Quarter Results

SunLink Health Systems, Inc. Announces Sale of Trace Extended Care & Rehab

SunLink Health Systems, Inc. Announces Fiscal 2024 Fourth Quarter and Annual Results

SunLink Health Systems, Inc. Announces Sale of Trace Regional Hospital Real Estate

Comments

SunLink Health Systems

Notizie

Ultime notizie per SunLink Health Systems (AMEX:SSY) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO